Scientific Company Obtains UK Accreditation for Good Laboratory Practice Monitoring, Strengthening Its Capabilities for Regulatory Research in Medicine, Devices, and New Products
In a significant milestone for Inter Scientific Ltd, the regulatory science company has been granted UK Good Laboratory Practice (GLP) status. This achievement underscores the company's commitment to delivering the highest standards of scientific and regulatory excellence.
The GLP status confirms that Inter Scientific's laboratories meet internationally recognised standards for the planning, performance, monitoring, recording, auditing, reporting, and archiving of laboratory studies. This ensures regulatory compliance and increases the reliability and integrity of scientific data produced by Inter Scientific Ltd.
Holding UK GLP status provides several benefits. Firstly, data generated under GLP are more readily accepted by regulatory authorities in the UK and internationally, facilitating drug development or product approval processes. This enhances Inter Scientific Ltd's ability to support clients needing regulatory submissions.
Secondly, the GLP status distinguishes Inter Scientific Ltd from non-GLP compliant competitors, positioning it as a trusted partner for pharmaceutical, biotech, and other regulated sectors seeking high-quality and compliant laboratory services.
Thirdly, with GLP accreditation, Inter Scientific Ltd can participate in studies and contracts requiring compliance with UK and OECD GLP standards, expanding its client base and collaboration potential.
The GLP framework also institutes rigorous quality assurance procedures, improving data reliability and minimising risks related to scientific misconduct or errors, thereby protecting the company’s reputation.
Inter Scientific Ltd offers a range of services, including laboratory testing and consultancy, and caters to various industries, including medicines, medical devices, cosmetics, and novel nicotine products. The company's multidisciplinary team of experts supports clients globally through all stages of product development and regulatory submission.
The GLP status is a major milestone for Inter Scientific Ltd, reflecting its dedication to delivering accurate, impartial regulatory studies that ultimately support public health. For more information about Inter Scientific Ltd's inclusion on the official UK GLP Compliance Monitoring Programme, please visit this link: https://assets.publishing.service.gov.uk/media/67c6d137b0bb6528ee866d94/Current-Members_of_the_UK_GLP_Compliance_monitoring_Programme_Version_15.pdf.
[1] GLP Monitoring Authority (2021) Good Laboratory Practice (GLP) Monitoring. Retrieved from https://www.gov.uk/guidance/good-laboratory-practice-glp-monitoring [2] OECD (2021) Good Laboratory Practice. Retrieved from https://www.oecd.org/chemicalsafety/testing/good-laboratory-practice-glp.htm [3] FDA (2021) Good Laboratory Practice for Nonclinical Laboratory Studies. Retrieved from https://www.fda.gov/regulatory-information/laws-enforcement-policies/good-laboratory-practice-glp-nonclinical-laboratory-studies
- Encouraged by the GLP status, Inter Scientific Ltd might expand its services to include cloud-based data management systems for more efficient handling of scientific data, further boosting its compliance with international standards and credibility.
- As a trusted partner in the health-and-wellness sector, Inter Scientific Ltd can leverage its GLP compliance to offer personalized therapies and treatments for medical conditions, thereby improving the overall quality of life for patients.
- To solidify its position as a global leader in regulatory science, Inter Scientific Ltd could potentially venture into creating news articles or scientific reports focusing on the latest advancements in cloud technologies, their role in GLP compliance, and their impact on health-and-wellness, therapies, and treatments.
